from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1741/vapC34

LFCtreatmentdescriptionclass of inhibitor

0.457

Amikacinug/mL Amikacintranslation

1.062

Cap5-10ug/mL Capreomycintranslation

1.959

Rox10-50 ug/mL Roxithromycintranslation

0.314

SM2-5 ug/mL Streptomycintranslation

0.633

Tet5-10 ug/mL Tetracyclinetranslation

0.650

Rif0.2-5ug/mL Rifampicintranscription

0.501

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.604

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.059

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.757

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.758

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.476

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.283

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.924

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.635

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.631

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.527

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

1.891

NaN30.2-2 mM Sodium aziderespiration

-1.755

Nigericin50 uM Nigericinrespiration

0.260

TRC10-150 ug/mL Triclosanrespiration

1.630

TRZ10-25 ug/mL Thioridazinerespiration

-1.409

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.413

menadione6-10 ug/mL Menadionerespiration

-0.349

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.151

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.742

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.081

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.325

NRP_1Non-replicating persistence stage 1dosRassociated

-0.368

Amp0.2mg/mL AmpicillincellWall

1.171

Cephalexin20-100 ug/mL CephalexincellWall

-0.180

Cerulenin0.32-5 ug/mL CerulenincellWall

0.027

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.593

EMB10-20 ug/mL EthambutolcellWall

-0.069

Eta12-40 ug/mL EthionamidecellWall

0.688

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.253

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.633

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.248

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.795

BZA0.12 mg/mL BenzamidearomaticAmides

-0.496

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.465

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.476

H2O24 mM hydrogen peroxideDNAdamaging

-0.044

Levo10 ug/mL LevofloxacinDNAdamaging

-0.471

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.250

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.184

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.016

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.618

Antimycin12.5-50 ug/mL Antimycin A?

-0.984

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.428

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.730

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.007

PA8240.2-2 ug/mL PA-824?

0.697

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.424

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.703

Verapamil50 uM Verapamil?

-0.535

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.713

methoxatin10-20 ug/mL Methoxatin?